查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1858784

活性素A：全球市场占有率和排名、总销售额和需求预测（2025-2031年）

Activin A - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 116 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球 Activin A 市场规模估计为 2,053 万美元，预计到 2031 年将达到 4,734 万美元，在 2025 年至 2031 年的预测期内，复合年增长率为 12.5%。

本报告对近期关税调整和国际战略反制措施对Activin A跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组的影响进行了全面评估。

激活素是一种二硫键连接的二聚体蛋白，属于TGF-β超家族，最初是从性腺液中纯化得到的，用于促进促睪固酮（FSH）的释放。激活素蛋白具有广泛的生物活性，包括参与中胚层诱导、神经元分化、骨骼重塑、造血和生殖生理等过程。激活素异构体和其他TGF-β超家族成员透过与I型和II型丝胺酸/苏胺酸激酶受体的异源复合物结合发挥其生物学效应，这些受体对于讯号传导至关重要。 2024年，全球激活素A的产量约为1115毫克，全球平均市场价格约为18.4美元/微克。

生殖和内分泌健康问题（例如癌症、纤维化疾病、卵巢症候群 (PCOS) 和不孕症）的日益增多，正推动对新型诊断标记和治疗标靶的快速需求。激活素 A 在细胞信号传导、免疫调节和组织重塑中发挥核心作用，这引起了生物製药公司和学术研究人员的关注。此外，再生医学和干细胞疗法的进展也推动了对调控干细胞命运和组织修復因子的需求，而激活素 A 在其中占据着尤为重要的地位。生物技术创新——例如改进的重组表达系统、增强的纯化和稳定性以及优化的递送系统——降低了生产成本和品质风险，从而使其应用范围从高端研究扩展到诊断和治疗产品。许多国家政府和监管政策以及公共资金对生物标记和精准医疗的支持，进一步拓展了市场成长机会。

儘管有许多机会，激活素A市场也面临重大风险。首先，激活素A的生物机制复杂且高度依赖具体情况。其作用可能因疾病状态、剂量、给药时间及组织类型而异，既可能带来益处，也可能造成损害。这使得中和剂和拮抗剂的治疗设计变得复杂，并增加了安全性和有效性的不确定性。其次，从研发到临床试验的过程漫长且高成本。在动物模型和人体中验证特定适应症的有效性和安全性需要大量的时间和资金投入，这构成了一大障碍，尤其对于中小企业而言。第三，不同地区的监理核准流程差异显着。品质、安全性、剂型、联合治疗和生物标记检验等方面的要求各不相同，监管政策的变更和延误可能会延长产品上市时间。此外，成熟的生物技术/製药公司、学术研究机构和Start-Ups之间的竞争日益激烈，因此，差异化、智慧财产权保护和有效的商业化策略至关重要。

下游需求正从纯粹的研究试剂转向诊断和治疗组合产品。儘管研究机构仍在购买激活素A蛋白、抗体和检测试剂套件，但诊断实验室和临床机构越来越多地将激活素A作为疾病（癌症、纤维化和发炎性疾病）早期检测的生物标记。生物製药公司正在开发针对激活素A的治疗药物（中和抗体、受体拮抗剂），用于抗纤维化、肿瘤抑制和促进组织再生等适应症。精准医疗/个人化治疗策略强调监测激活素A的浓度或活性，以进行患者分层。从区域来看，新兴地区（亚洲、拉丁美洲和中东）正在增加对医疗研究基础设施的投资，与成熟市场相比，这推动了激活素A相关产品需求的更快成长。

上游工程原料包括重组激活素A表达系统（例如，细菌、酵母和哺乳动物细胞株）、培养基和组分、纯化培养基和缓衝液、稳定性增强剂、品管试剂和分析试剂，以及中和抗体或拮抗剂。单线生产能力是指从表达→纯化→品管→製剂/稳定性测试（液体/冷冻干燥）→包装和分销的完整生产线。在这个生产线中，表达系统的选择和正确的折迭/修饰是关键瓶颈。纯化和去除内毒素及非预期杂质需要先进的技术。品管，包括生物活性测试和安全检验，决定了产品是否达到临床级标准或仍处于研究级标准。研究试剂/ELISA级激活素A产品具有单线部署前置作业时间短、投资成本低的优点。然而，治疗性产品（尤其是中和抗体、受体拮抗剂或透过新型递送系统递送的产品）需要更多的资金、设施、熟练的人员以及更长的研发和检验週期。

本报告旨在对全球 Activin A 市场按地区/国家、类型和应用进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

本报告以销售量（毫克）和收入（百万美元）为单位，提供Activin A的市场规模、估算和预测，基准年为2024年，并包含2020年至2031年的历史数据和预测数据。定量和定性分析相结合，帮助读者制定业务/成长策略、评估市场竞争、分析自身在当前市场中的地位，并就Activin A做出明智的商业决策。

市场区隔

公司

  • Merck Millipore
  • Thermo Fisher Scientific
  • Bio-Techne
  • StemRD
  • Prospec
  • Proteintech Group
  • Ajinomoto
  • Enzo Life Sciences
  • IBL
  • STEMCELL
  • Sino Biological
  • PeproTech
  • ReproCELL

按类型分類的细分市场

  • 人类激活素A
  • Activin A 小鼠（大鼠）

应用领域

  • 商业研究
  • 学术研究

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Activin A was estimated to be worth US$ 20.53 million in 2024 and is forecast to a readjusted size of US$ 47.34 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Activin A cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Activins, members of the TGF-beta superfamily, are disulfide-linked dimeric proteins originally purified from gonadal fluids as proteins that stimulated pituitary follicle stimulating hormone (FSH) release. Activin proteins have a wide range of biological activities, including mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis and roles in reproductive physiology. Activin isoforms and other members of the TGF-beta superfamily exert their biological effects by binding to heteromeric complexes of a type I and a type II serine-threonine kinase receptor, both of which are essential for signal transduction.In 2024, global Activin A production reached approximately 1115 mg, with an average global market price of around 18.4 USD/µg

With the rising incidence of cancers, fibrotic disorders, and reproductive / endocrine health issues such as PCOS or infertility, there is sharply increasing demand for novel diagnostic markers and therapeutic targets. Activin A's central role in cellular signaling, immune modulation and tissue remodeling is drawing heightened attention from biopharma and academic researchers. In addition, the rise of regenerative medicine and stem cell therapies fuels demand for factors that can regulate stem cell fate and tissue repair, among which Activin A is prominent. Biotechnology innovations-improvements in recombinant expression systems, purification and stability enhancements, as well as delivery system optimization-are reducing production costs and risks of quality, enabling broader application from only high-end research to diagnostics and therapeutic products. Government and regulatory policies in many countries supporting biomarkers and precision medicine, along with public funding, further release opportunities for market growth.

Despite many opportunities, the Activin A market faces notable risks. First, the biological mechanisms of Activin A are complex and highly context-dependent: its effects may be beneficial or harmful depending on disease state, dose, timing and tissue, which complicates therapeutic designs of neutralizing agents or antagonists and raises safety/efficacy uncertainties. Second, the R&D to clinical clinical trial path is long and expensive; proving efficacy and safety in specific indications in animal models and humans requires substantial investment in time and money, which is a barrier especially for smaller firms. Third, regulatory approval pathways vary widely across geographies: quality, safety, delivery format, combination therapies, and biomarker validation are addressed differently, and changes or delays in regulation can lengthen time to market. Also, competition is intensifying among established biotech / pharmaceutical companies, academic labs, and startups; differentiation, intellectual property protection, and effective commercialization strategies become critical.

Downstream demand is shifting from purely research reagents toward combined diagnostics + therapeutics. Research institutions continue to purchase Activin A proteins, antibodies, and assay kits, but diagnostic laboratories and clinical settings are increasingly adopting Activin A as a biomarker for early disease detection (cancer, fibrosis, inflammatory diseases). Biopharma firms are progressing therapeutic development targeting Activin A (neutralizing antibodies, receptor antagonists) in indication areas such as antifibrosis, tumor suppression, and enhancing tissue regeneration. Precision medicine / personalized therapeutic strategies are favoring monitoring of Activin A levels or activity for patient stratification. Geographically, emerging regions (Asia, Latin America, Middle East) are increasing their investment in health research infrastructure, so demand growth in Activin A-related products is accelerating there relative to mature markets

Upstream raw inputs include recombinant Activin A expression systems (e.g. bacterial, yeast, mammalian cell lines), culture media and components, purification media and buffers, stability enhancers, QC reagents and analytical assays, antibodies or antagonists for neutralization, etc. A single-line capacity refers to a full production line from expression -> purification -> quality control -> formulation/stability (liquid / freeze-dried) -> packaging & distribution. Within such a line, expression system choice and correct folding / modification are key bottlenecks; purification and removal of endotoxins or unintended impurities are demanding; QC including bioactivity assays and safety validations determine whether outputs meet clinical-grade or just research-grade standards. Research reagent / ELISA-level Activin A products have shorter lead times and lower investment for single-line deployment; but therapeutic products-especially neutralizing antibodies, receptor antagonists, or those delivered via novel delivery systems-require much larger capital, facilities, skilled personnel, and longer development & validation times.

This report aims to provide a comprehensive presentation of the global market for Activin A, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Activin A by region & country, by Type, and by Application.

The Activin A market size, estimations, and forecasts are provided in terms of sales volume (mg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Activin A.

Market Segmentation

By Company

  • Merck Millipore
  • Thermo Fisher Scientific
  • Bio-Techne
  • StemRD
  • Prospec
  • Proteintech Group
  • Ajinomoto
  • Enzo Life Sciences
  • IBL
  • STEMCELL
  • Sino Biological
  • PeproTech
  • ReproCELL

Segment by Type

  • Activin-A Human
  • Activin-A Mouse (Rat)

Segment by Application

  • Commercial Research
  • Academic Research

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Activin A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Activin A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Activin A in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Activin A Product Introduction
  • 1.2 Global Activin A Market Size Forecast
    • 1.2.1 Global Activin A Sales Value (2020-2031)
    • 1.2.2 Global Activin A Sales Volume (2020-2031)
    • 1.2.3 Global Activin A Sales Price (2020-2031)
  • 1.3 Activin A Market Trends & Drivers
    • 1.3.1 Activin A Industry Trends
    • 1.3.2 Activin A Market Drivers & Opportunity
    • 1.3.3 Activin A Market Challenges
    • 1.3.4 Activin A Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Activin A Players Revenue Ranking (2024)
  • 2.2 Global Activin A Revenue by Company (2020-2025)
  • 2.3 Global Activin A Players Sales Volume Ranking (2024)
  • 2.4 Global Activin A Sales Volume by Company Players (2020-2025)
  • 2.5 Global Activin A Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Activin A Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Activin A Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Activin A
  • 2.9 Activin A Market Competitive Analysis
    • 2.9.1 Activin A Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Activin A Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Activin A as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Activin-A Human
    • 3.1.2 Activin-A Mouse (Rat)
  • 3.2 Global Activin A Sales Value by Type
    • 3.2.1 Global Activin A Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Activin A Sales Value, by Type (2020-2031)
    • 3.2.3 Global Activin A Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Activin A Sales Volume by Type
    • 3.3.1 Global Activin A Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Activin A Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Activin A Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Activin A Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Commercial Research
    • 4.1.2 Academic Research
  • 4.2 Global Activin A Sales Value by Application
    • 4.2.1 Global Activin A Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Activin A Sales Value, by Application (2020-2031)
    • 4.2.3 Global Activin A Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Activin A Sales Volume by Application
    • 4.3.1 Global Activin A Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Activin A Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Activin A Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Activin A Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Activin A Sales Value by Region
    • 5.1.1 Global Activin A Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Activin A Sales Value by Region (2020-2025)
    • 5.1.3 Global Activin A Sales Value by Region (2026-2031)
    • 5.1.4 Global Activin A Sales Value by Region (%), (2020-2031)
  • 5.2 Global Activin A Sales Volume by Region
    • 5.2.1 Global Activin A Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Activin A Sales Volume by Region (2020-2025)
    • 5.2.3 Global Activin A Sales Volume by Region (2026-2031)
    • 5.2.4 Global Activin A Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Activin A Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Activin A Sales Value, 2020-2031
    • 5.4.2 North America Activin A Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Activin A Sales Value, 2020-2031
    • 5.5.2 Europe Activin A Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Activin A Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Activin A Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Activin A Sales Value, 2020-2031
    • 5.7.2 South America Activin A Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Activin A Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Activin A Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Activin A Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Activin A Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Activin A Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Activin A Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Activin A Sales Value, 2020-2031
    • 6.3.2 United States Activin A Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Activin A Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Activin A Sales Value, 2020-2031
    • 6.4.2 Europe Activin A Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Activin A Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Activin A Sales Value, 2020-2031
    • 6.5.2 China Activin A Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Activin A Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Activin A Sales Value, 2020-2031
    • 6.6.2 Japan Activin A Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Activin A Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Activin A Sales Value, 2020-2031
    • 6.7.2 South Korea Activin A Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Activin A Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Activin A Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Activin A Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Activin A Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Activin A Sales Value, 2020-2031
    • 6.9.2 India Activin A Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Activin A Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Merck Millipore
    • 7.1.1 Merck Millipore Company Information
    • 7.1.2 Merck Millipore Introduction and Business Overview
    • 7.1.3 Merck Millipore Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Merck Millipore Activin A Product Offerings
    • 7.1.5 Merck Millipore Recent Development
  • 7.2 Thermo Fisher Scientific
    • 7.2.1 Thermo Fisher Scientific Company Information
    • 7.2.2 Thermo Fisher Scientific Introduction and Business Overview
    • 7.2.3 Thermo Fisher Scientific Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Thermo Fisher Scientific Activin A Product Offerings
    • 7.2.5 Thermo Fisher Scientific Recent Development
  • 7.3 Bio-Techne
    • 7.3.1 Bio-Techne Company Information
    • 7.3.2 Bio-Techne Introduction and Business Overview
    • 7.3.3 Bio-Techne Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Bio-Techne Activin A Product Offerings
    • 7.3.5 Bio-Techne Recent Development
  • 7.4 StemRD
    • 7.4.1 StemRD Company Information
    • 7.4.2 StemRD Introduction and Business Overview
    • 7.4.3 StemRD Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 StemRD Activin A Product Offerings
    • 7.4.5 StemRD Recent Development
  • 7.5 Prospec
    • 7.5.1 Prospec Company Information
    • 7.5.2 Prospec Introduction and Business Overview
    • 7.5.3 Prospec Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Prospec Activin A Product Offerings
    • 7.5.5 Prospec Recent Development
  • 7.6 Proteintech Group
    • 7.6.1 Proteintech Group Company Information
    • 7.6.2 Proteintech Group Introduction and Business Overview
    • 7.6.3 Proteintech Group Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Proteintech Group Activin A Product Offerings
    • 7.6.5 Proteintech Group Recent Development
  • 7.7 Ajinomoto
    • 7.7.1 Ajinomoto Company Information
    • 7.7.2 Ajinomoto Introduction and Business Overview
    • 7.7.3 Ajinomoto Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Ajinomoto Activin A Product Offerings
    • 7.7.5 Ajinomoto Recent Development
  • 7.8 Enzo Life Sciences
    • 7.8.1 Enzo Life Sciences Company Information
    • 7.8.2 Enzo Life Sciences Introduction and Business Overview
    • 7.8.3 Enzo Life Sciences Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Enzo Life Sciences Activin A Product Offerings
    • 7.8.5 Enzo Life Sciences Recent Development
  • 7.9 IBL
    • 7.9.1 IBL Company Information
    • 7.9.2 IBL Introduction and Business Overview
    • 7.9.3 IBL Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 IBL Activin A Product Offerings
    • 7.9.5 IBL Recent Development
  • 7.10 STEMCELL
    • 7.10.1 STEMCELL Company Information
    • 7.10.2 STEMCELL Introduction and Business Overview
    • 7.10.3 STEMCELL Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 STEMCELL Activin A Product Offerings
    • 7.10.5 STEMCELL Recent Development
  • 7.11 Sino Biological
    • 7.11.1 Sino Biological Company Information
    • 7.11.2 Sino Biological Introduction and Business Overview
    • 7.11.3 Sino Biological Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Sino Biological Activin A Product Offerings
    • 7.11.5 Sino Biological Recent Development
  • 7.12 PeproTech
    • 7.12.1 PeproTech Company Information
    • 7.12.2 PeproTech Introduction and Business Overview
    • 7.12.3 PeproTech Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 PeproTech Activin A Product Offerings
    • 7.12.5 PeproTech Recent Development
  • 7.13 ReproCELL
    • 7.13.1 ReproCELL Company Information
    • 7.13.2 ReproCELL Introduction and Business Overview
    • 7.13.3 ReproCELL Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 ReproCELL Activin A Product Offerings
    • 7.13.5 ReproCELL Recent Development

8 Industry Chain Analysis

  • 8.1 Activin A Industrial Chain
  • 8.2 Activin A Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Activin A Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Activin A Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Activin A Market Trends
  • Table 2. Activin A Market Drivers & Opportunity
  • Table 3. Activin A Market Challenges
  • Table 4. Activin A Market Restraints
  • Table 5. Global Activin A Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Activin A Revenue Market Share by Company (2020-2025)
  • Table 7. Global Activin A Sales Volume by Company (2020-2025) & (mg)
  • Table 8. Global Activin A Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Activin A Price by Company (2020-2025) & (US$/mg)
  • Table 10. Key Manufacturers Activin A Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Activin A Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Activin A
  • Table 13. Global Activin A Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Activin A as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Activin A Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Activin A Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Activin A Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Activin A Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Activin A Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Activin A Sales Volume by Type: 2020 VS 2024 VS 2031 (mg)
  • Table 22. Global Activin A Sales Volume by Type (2020-2025) & (mg)
  • Table 23. Global Activin A Sales Volume by Type (2026-2031) & (mg)
  • Table 24. Global Activin A Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Activin A Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Activin A Price by Type (2020-2025) & (US$/mg)
  • Table 27. Global Activin A Price by Type (2026-2031) & (US$/mg)
  • Table 28. Global Activin A Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Activin A Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Activin A Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Activin A Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Activin A Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Activin A Sales Volume by Application: 2020 VS 2024 VS 2031 (mg)
  • Table 34. Global Activin A Sales Volume by Application (2020-2025) & (mg)
  • Table 35. Global Activin A Sales Volume by Application (2026-2031) & (mg)
  • Table 36. Global Activin A Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Activin A Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Activin A Price by Application (2020-2025) & (US$/mg)
  • Table 39. Global Activin A Price by Application (2026-2031) & (US$/mg)
  • Table 40. Global Activin A Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Activin A Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Activin A Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Activin A Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Activin A Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Activin A Sales Volume by Region (mg): 2020 VS 2024 VS 2031
  • Table 46. Global Activin A Sales Volume by Region (2020-2025) & (mg)
  • Table 47. Global Activin A Sales Volume by Region (2026-2031) & (mg)
  • Table 48. Global Activin A Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Activin A Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Activin A Average Price by Region (2020-2025) & (US$/mg)
  • Table 51. Global Activin A Average Price by Region (2026-2031) & (US$/mg)
  • Table 52. Key Countries/Regions Activin A Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Activin A Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Activin A Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Activin A Sales Volume, (2020-2025) & (mg)
  • Table 56. Key Countries/Regions Activin A Sales Volume, (2026-2031) & (mg)
  • Table 57. Merck Millipore Company Information
  • Table 58. Merck Millipore Introduction and Business Overview
  • Table 59. Merck Millipore Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 60. Merck Millipore Activin A Product Offerings
  • Table 61. Merck Millipore Recent Development
  • Table 62. Thermo Fisher Scientific Company Information
  • Table 63. Thermo Fisher Scientific Introduction and Business Overview
  • Table 64. Thermo Fisher Scientific Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 65. Thermo Fisher Scientific Activin A Product Offerings
  • Table 66. Thermo Fisher Scientific Recent Development
  • Table 67. Bio-Techne Company Information
  • Table 68. Bio-Techne Introduction and Business Overview
  • Table 69. Bio-Techne Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 70. Bio-Techne Activin A Product Offerings
  • Table 71. Bio-Techne Recent Development
  • Table 72. StemRD Company Information
  • Table 73. StemRD Introduction and Business Overview
  • Table 74. StemRD Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 75. StemRD Activin A Product Offerings
  • Table 76. StemRD Recent Development
  • Table 77. Prospec Company Information
  • Table 78. Prospec Introduction and Business Overview
  • Table 79. Prospec Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 80. Prospec Activin A Product Offerings
  • Table 81. Prospec Recent Development
  • Table 82. Proteintech Group Company Information
  • Table 83. Proteintech Group Introduction and Business Overview
  • Table 84. Proteintech Group Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 85. Proteintech Group Activin A Product Offerings
  • Table 86. Proteintech Group Recent Development
  • Table 87. Ajinomoto Company Information
  • Table 88. Ajinomoto Introduction and Business Overview
  • Table 89. Ajinomoto Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 90. Ajinomoto Activin A Product Offerings
  • Table 91. Ajinomoto Recent Development
  • Table 92. Enzo Life Sciences Company Information
  • Table 93. Enzo Life Sciences Introduction and Business Overview
  • Table 94. Enzo Life Sciences Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 95. Enzo Life Sciences Activin A Product Offerings
  • Table 96. Enzo Life Sciences Recent Development
  • Table 97. IBL Company Information
  • Table 98. IBL Introduction and Business Overview
  • Table 99. IBL Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 100. IBL Activin A Product Offerings
  • Table 101. IBL Recent Development
  • Table 102. STEMCELL Company Information
  • Table 103. STEMCELL Introduction and Business Overview
  • Table 104. STEMCELL Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 105. STEMCELL Activin A Product Offerings
  • Table 106. STEMCELL Recent Development
  • Table 107. Sino Biological Company Information
  • Table 108. Sino Biological Introduction and Business Overview
  • Table 109. Sino Biological Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 110. Sino Biological Activin A Product Offerings
  • Table 111. Sino Biological Recent Development
  • Table 112. PeproTech Company Information
  • Table 113. PeproTech Introduction and Business Overview
  • Table 114. PeproTech Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 115. PeproTech Activin A Product Offerings
  • Table 116. PeproTech Recent Development
  • Table 117. ReproCELL Company Information
  • Table 118. ReproCELL Introduction and Business Overview
  • Table 119. ReproCELL Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 120. ReproCELL Activin A Product Offerings
  • Table 121. ReproCELL Recent Development
  • Table 122. Key Raw Materials Lists
  • Table 123. Raw Materials Key Suppliers Lists
  • Table 124. Activin A Downstream Customers
  • Table 125. Activin A Distributors List
  • Table 126. Research Programs/Design for This Report
  • Table 127. Key Data Information from Secondary Sources
  • Table 128. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Activin A Product Picture
  • Figure 2. Global Activin A Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Activin A Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Activin A Sales Volume (2020-2031) & (mg)
  • Figure 5. Global Activin A Sales Price (2020-2031) & (US$/mg)
  • Figure 6. Activin A Report Years Considered
  • Figure 7. Global Activin A Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Activin A Players Sales Volume Ranking (2024) & (mg)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Activin A Revenue in 2024
  • Figure 10. Activin A Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Activin-A Human Picture
  • Figure 12. Activin-A Mouse (Rat) Picture
  • Figure 13. Global Activin A Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Activin A Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Activin A Sales Volume by Type (2020 VS 2024 VS 2031) & (mg)
  • Figure 16. Global Activin A Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Activin A Price by Type (2020-2031) & (US$/mg)
  • Figure 18. Product Picture of Commercial Research
  • Figure 19. Product Picture of Academic Research
  • Figure 20. Global Activin A Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 21. Global Activin A Sales Value Market Share by Application, 2024 & 2031
  • Figure 22. Global Activin A Sales Volume by Application (2020 VS 2024 VS 2031) & (mg)
  • Figure 23. Global Activin A Sales Volume Market Share by Application, 2024 & 2031
  • Figure 24. Global Activin A Price by Application (2020-2031) & (US$/mg)
  • Figure 25. North America Activin A Sales Value (2020-2031) & (US$ Million)
  • Figure 26. North America Activin A Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Europe Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. Europe Activin A Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Asia Pacific Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Asia Pacific Activin A Sales Value by Region (%), 2024 VS 2031
  • Figure 31. South America Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. South America Activin A Sales Value by Country (%), 2024 VS 2031
  • Figure 33. Middle East & Africa Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Middle East & Africa Activin A Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Key Countries/Regions Activin A Sales Value (%), (2020-2031)
  • Figure 36. Key Countries/Regions Activin A Sales Volume (%), (2020-2031)
  • Figure 37. United States Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. United States Activin A Sales Value by Type (%), 2024 VS 2031
  • Figure 39. United States Activin A Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Europe Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. Europe Activin A Sales Value by Type (%), 2024 VS 2031
  • Figure 42. Europe Activin A Sales Value by Application (%), 2024 VS 2031
  • Figure 43. China Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. China Activin A Sales Value by Type (%), 2024 VS 2031
  • Figure 45. China Activin A Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Japan Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. Japan Activin A Sales Value by Type (%), 2024 VS 2031
  • Figure 48. Japan Activin A Sales Value by Application (%), 2024 VS 2031
  • Figure 49. South Korea Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. South Korea Activin A Sales Value by Type (%), 2024 VS 2031
  • Figure 51. South Korea Activin A Sales Value by Application (%), 2024 VS 2031
  • Figure 52. Southeast Asia Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 53. Southeast Asia Activin A Sales Value by Type (%), 2024 VS 2031
  • Figure 54. Southeast Asia Activin A Sales Value by Application (%), 2024 VS 2031
  • Figure 55. India Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 56. India Activin A Sales Value by Type (%), 2024 VS 2031
  • Figure 57. India Activin A Sales Value by Application (%), 2024 VS 2031
  • Figure 58. Activin A Industrial Chain
  • Figure 59. Activin A Manufacturing Cost Structure
  • Figure 60. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 61. Bottom-up and Top-down Approaches for This Report
  • Figure 62. Data Triangulation
  • Figure 63. Key Executives Interviewed